Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Laboratories (ABT): Today's Featured Drugs Laggard
The Street
Saturday, September 29, 2012 - 12:16pm
tags:
Abbott Laboratories
Sanofi (SNY): Today's Featured Health Care Laggard
The Street
Saturday, September 29, 2012 - 12:15pm
tags:
Sanofi
Pharma Is on Fire
Motley Fool
Saturday, September 29, 2012 - 12:14pm
tags:
Action Pharma
Abbott's Humira (adalimumab) Receives U.S. FDA Approval for the Treatment of Adult Patients with Moderate to Severe Ulcerative Colitis
Yahoo/PR Newswire
Saturday, September 29, 2012 - 12:14pm
tags:
Abbott Laboratories, Humira, ulcerative colitis
Investors may overlook Abbott executive's false degrees
Reuters
Saturday, September 29, 2012 - 12:12pm
tags:
Abbott Laboratories
This Stock Rocks as Its Drug Rolls Ahead
Motley Fool
Saturday, September 29, 2012 - 12:11pm
tags:
Ariad Pharmaceuticals, Ponatinib, chronic myelogenous leukemia, leukemia
Is This Pharma Stock a Good Investment?
Motley Fool
Saturday, September 29, 2012 - 12:08pm
tags:
Questcor Pharmaceuticals
Insmed Ignites Higher and 4 Healthcare Stocks to Analyze Now
Wall Street Cheat Street
Saturday, September 29, 2012 - 12:08pm
tags:
Insmed, Dendreon, Peregrine Pharmaceuticals, Vivus, Arena Pharmaceuticals
What's Fueling Savient's Run?
Motley Fool
Saturday, September 29, 2012 - 12:06pm
tags:
Savient
ARIAD Presents Initial Clinical Proof-of-Concept of AP26113 in Patients with Non-Small Cell Lung Cancer at ESMO 2012 Congress
Yahoo/BusinessWire
Saturday, September 29, 2012 - 12:02pm
tags:
non-small cell lung cancer, Ariad Pharmaceuticals, AP26113
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Yahoo/BusinessWire
Saturday, September 29, 2012 - 11:59am
tags:
Exelixis, GDC-0973, XL518, melanoma
Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients
Bloomberg
Saturday, September 29, 2012 - 11:57am
tags:
Nexavar, Bayer, lung cancer
Glaxo Two-Drug Melanoma Combo Slows Cancer in Study
Bloomberg
Saturday, September 29, 2012 - 11:55am
tags:
GSK, melanoma, dabrafenib, trametinib
Pomerantz Law Firm Has Filed a Class Action Against Peregrine Pharmaceuticals, Inc. -- PPHM
Yahoo/GlobeNewsWire
Saturday, September 29, 2012 - 11:53am
tags:
Peregrine Pharmaceuticals, lawsuits
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.
Yahoo/BusinessWire
Saturday, September 29, 2012 - 11:51am
tags:
Questcor Pharmaceuticals, lawsuits
Is Novo Nordisk the Perfect Stock?
Motley Fool
Saturday, September 29, 2012 - 11:51am
tags:
Novo Nordisk
Twin Orphan Drug News
Motley Fool
Saturday, September 29, 2012 - 11:50am
tags:
Biomarin, orphan drugs, Peg-Pal, phenylketonuria, Kuvan
A Home Run Drug in the Holy Land
Motley Fool
Saturday, September 29, 2012 - 11:48am
tags:
Elelyso, Gaucher disease, Protalix BioTherapeutics
Novo Nordisk halts development of hemophilia drug
Reuters
Friday, September 28, 2012 - 12:11pm
tags:
Novo Nordisk, hemophilia, vatreptacog alfa, NovoSeven
Cell Therapeutics: European Revenue Opportunity Could Represent A Turning Point
Seeking Alpha
Friday, September 28, 2012 - 12:02pm
tags:
Cell Therapeutics, Europe, Pixuvri, non-Hodgkin B-cell lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.